Dr. med. Dipl. biol. Bernd Löffler
Creator and founder of ageLine®

After years of practice and research at renowned institutions such as the Max Planck Institute for Experimental Medicine and Hoffmann-La-Roche, Dr. Bernd Löffler founded the Institute for Preventive & Aesthetic Medicine in 2005 and later the Institute for Mitochondrial Medicine.
Here he and his Team are researching how aging processes of patients can be decelerated based on state-of-the-art medical expertise, e.g. using mitochondrial medicine, dealing with the energy and metabolic processes of cells, including skin aging.
Credentials
Development of medications
Major part in development of 2 medications:
-
Tracleer (Bosentan) for PAH (pulmonary arterial hypertension)
-
SPP301 for diabetic nephropathy (Fast Track status granted in December 2006)
-
Publications
77 publications, 50 international patents, more than 200 lectures and congress papers
Expert activities
DFG, ÖFG, Hypertension, FEBS
Member of
-
Society of German Chemists
-
German Society of Biochemistry and Molecular Biology
-
Forum Orthomolecular Medicine
-
German Society of Preventive Medicine
-
German Society for Anti-Ageing Medicine
-
American Association for Anti-Ageing Medicine
-
American Heart Association
-
American Diabetes Association
Career
1975 – 1985
Studies of Human Medicine, Biology, Chemistry and Physics at the Georg-August-University Göttingen
1981
Diploma in Biology, Focus on biochemistry with Summa cum Laude
1986
Doctorate in medicine with Summa cum Laude
1978 – 1980
Scientific assistant at the Institute of Plant Biochemistry, University of Göttingen Deputy Head PD Dr. Harnischfeger
1980 – 1984
Scientific assistant at the Max Planck Institute for Experimental Medicine, Research Group Prof. Dr. H. Kunze, Department Prof. Dr. W. Vogt
1985 – 1989
Scientific researcher at the Max Planck Institute for Experimental Medicine, Research Group Prof. Dr. H. Kunze, Department Prof. Dr. W. Vogt
1988
Guest professor at the University of Edmonton, Canada, working group Prof. Dr. D.N. Brindley
1989 – 2005
Preclinical research F. Hoffmann-La Roche (Basel) since 2002 in the function of a Vice-Director
2003 – 2004
Education in men’s medical care at HOMMAGE
Since 2004
Continuous education in Orthomolecular and Preventive Medicine
April 2005
Founding of Löffler Consulting in Zug (Switzerland), scientific advice for research-based pharmaceutical companies (e.g. F. Hoffmann-La Roche, Santhera, Biovitrum)
May 2005
Founding IPAM (Institute for Prevention and Antiaging Medicine)
Development of medical products, lectures, preventive medical education
December 2006
Summoned in the Scientific Advisory Board of Santhera Pharmaceuticals AG
February 2007
Private practice for preventive medicine (formerly Platz vor dem neuen Tor 5, 10115 Berlin, enlargement of practice rooms from 01.02.2007 in Knesebeckstrasse 68/69, 10623 Berlin)
Since December 2006
Member of the Scientific Advisory Board of Santhera Pharmaceuticals
Research focus: testosterone biosynthesis regulation, lysosomal phospholipid metabolism, renin-angiotensin system, endothelin system, dipeptidyl peptidase IV
1989 – 2000
Cardiovascular disease, SAH (subarachnoid hemorrhage)
2000 – 2005
Metabolic disorders (Main focus: type II diabetes, metabolic syndrome)